Morgan Stanley
MLTX icon

Morgan Stanley’s MoonLake Immunotherapeutics MLTX Stock Holding History

Morgan Stanley’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5M Sell
614,482
-430,099
-41% -$7.12M ﹤0.01% 3461
2025
Q4 		$13.8M Buy
1,044,581
+787,926
+307% +$9.3M ﹤0.01% 3301
2025
Q3 		$1.84M Buy
256,655
+213,416
+494% +$11.1M ﹤0.01% 4838
2025
Q2 		$2.04M Sell
43,239
-11,092
-20% -$452K ﹤0.01% 4687
2025
Q1 		$2.12M Buy
54,331
+7,187
+15% +$310K ﹤0.01% 4569
2024
Q4 		$2.55M Sell
47,144
-83,454
-64% -$4.26M ﹤0.01% 4536
2024
Q3 		$6.58M Buy
130,598
+61,571
+89% +$2.89M ﹤0.01% 3744
2024
Q2 		$3.04M Sell
69,027
-160,155
-70% -$6.78M ﹤0.01% 4276
2024
Q1 		$11.5M Buy
229,182
+96,154
+72% +$5.22M ﹤0.01% 3230
2023
Q4 		$8.03M Buy
133,028
+123,577
+1,308% +$6.37M ﹤0.01% 4081
2023
Q3 		$539K Sell
9,451
-149,974
-94% -$8.28M ﹤0.01% 5136
2023
Q2 		$8.13M Buy
159,425
+126,906
+390% +$3.41M ﹤0.01% 3359
2023
Q1 		$696K Buy
32,519
+5,154
+19% +$86.7K ﹤0.01% 5065
2022
Q4 		$287K Buy
27,365
+24,265
+783% +$216K ﹤0.01% 5511
2022
Q3 		$24K Buy
+3,100
New +$21.9K ﹤0.01% 6715
2022
Q1 		– Sell
-13,449
Closed -$133K – 8057
2021
Q4 		$133K Hold
13,449
– – ﹤0.01% 6278
2021
Q3 		$132K Buy
13,449
+7,549
+128% +$75.3K ﹤0.01% 6215
2021
Q2 		$61K Sell
5,900
-1
-0% -$10 ﹤0.01% 6587
2021
Q1 		$60K Buy
5,901
+5,900
+590,000% +$65K ﹤0.01% 6273
2020
Q4 		$0 Buy
+1
New +$11 ﹤0.01% 7076

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return